NCT06585345
Clinical Study on the Safety and Efficacy of CD7 CAR-T Cell in Patients With Relapsed/Refractory Acute Leukemia No drug interventions treatment 1 / 2 recruiting NCT02058888
Amplification and Selection of Antimicrobial Resistance in the Intestine No drug interventions Not Available Not Available completed NCT00795132
Hematopoietic Cell Transplantation for Pediatric Patients With Hematologic Malignancies treatment 2 completed NCT00570999
Palifermin After Haploidentical PBSCT treatment 2 withdrawn NCT02123836
Natural Killer Cells in Acute Leukaemia and Myelodysplastic Syndrome treatment 1 unknown_status NCT00993538
Leukemia Cell Cultures for Research of New Anti-Cancer Therapies No drug interventions basic_science Not Available unknown_status NCT01521611
Targeted Radiotherapy in HSCT for Poor Risk Haematological Malignancy No drug interventions treatment 1 / 2 completed NCT01890746
A Safety and Efficacy Study of Eltrombopag in Subjects With AML No drug interventions treatment 2 completed NCT05521087
A Study of JNJ-75276617 in Combination With Conventional Chemotherapy for Pediatric and Young Adult Participants With Relapsed/Refractory Acute Leukemias treatment 1 withdrawn NCT02141828
A Phase 1 Dose Escalation and Expanded Cohort Study of EPZ-5676 in the Treatment of Pediatric Patients With Relapsed/Refractory Leukemias Bearing a Rearrangement of the MLL Gene treatment 1 completed NCT02145039
Reduced Intensity Conditioning and Haploidentical Related Bone Marrow for Patients With Hematologic Diseases treatment Not Available terminated NCT01479582
Providing Access to Cord Blood Units for Transplants No drug interventions treatment 2 withdrawn NCT01826214
Study of Efficacy and Safety of LDE225 in Adult Patients With Relapsed/Refractory Acute Leukemia treatment 2 completed NCT01339988
Busulfan and Cyclophosphamide Instead of Total Boby Irradiation (TBI) and Cyclophosphamide for Hematological Malignancies Hematocrit (HCT) treatment 4 unknown_status NCT01919866
Safety Study of CD3/CD19 Depleted Haploidentical Stem Cells No drug interventions treatment 1 / 2 unknown_status NCT04811560
A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia treatment 1 / 2 recruiting NCT01334060
WT1 Immunity Via DNA Fusion Gene Vaccination in Haematological Malignancies by Intramuscular Injection Followed by Intramuscular Electroporation No drug interventions treatment 2 completed NCT03680677
Frailty Phenotype Assessments to Optimize Treatment Strategies for Older Patients With Hematologic Malignancies No drug interventions Not Available Not Available recruiting NCT05823571
Itacitinib With High-dose Posttransplantation Cyclophosphamide in Older Patients treatment 1 recruiting NCT03336632
Chidamide Plus PTCy/Cyclosporine to Prevent GVHD After Myeloablative Conditioning, Matched PBSCT treatment 2 unknown_status NCT05969600
The Relapses in Childhood Acute Lymphoplastic Leukemia Excluding L3 No drug interventions Not Available Not Available completed NCT04745416
Clinical Characteristics of Patients With Leukemia and COVID-19 No drug interventions Not Available Not Available completed NCT05236296
Emotion and Symptom-focused Engagement for Caregivers (EASE-CG) Pilot Study No drug interventions supportive_care Not Available recruiting NCT04236063
Rehabilitation Needs of the Malaysian Haematological Cancer Survivors No drug interventions Not Available Not Available completed NCT04194086
Population Pharmacokinetics and Safety of Oral Posaconazole in Children With Leukemia treatment 1 / 2 completed NCT03297476
Clinical Application of Novel Panels for Early Precision Diagnosis and Relapse Prediction in High-risk Leukemia No drug interventions Not Available Not Available completed NCT03553238
Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult ETP-ALL treatment 2 / 3 unknown_status NCT01050764
Haploidentical Allogeneic Transplant With Post-transplant Infusion of Regulatory T-cells treatment 1 / 2 terminated NCT06335277
Total Body Irradiation Treatments for Patients Treated at European Institute of Oncology No drug interventions Not Available Not Available recruiting NCT03564470
Precision Diagnosis Directing HDACi and TKI Target Therapy for Adult Ph-like ALL treatment 2 / 3 unknown_status NCT03963024
Treosulfan-TMI Conditioning and Rapamycin GvHD Prophylaxis Before Allo-HSCT treatment 1 terminated NCT04051216
The SMART CART Study: Health Information Technology No drug interventions supportive_care Not Available completed NCT04482894
Palliative Care Oncology in Patients With Relapsed, Refractory, and High-Risk Leukemias or MDS No drug interventions supportive_care 2 recruiting NCT03434704
Peripheral Blood Stem Cell Transplantation From Family Haploidentical Donors in Patients With Myelodysplastic Syndrome and Acute Leukemia Under Primary Prophylaxis With Posaconazole treatment 2 completed NCT03564704
Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL treatment 2 / 3 unknown_status NCT04710212
Screening for Colonization With Resistant Enterobacterales in Neutropenic Patients With Hematologic Malignancies No drug interventions Not Available Not Available completed NCT01800643
Evaluation of Plasmatic Levels of Busulfan in Patients Undergoing Hematopoietic Stem Cell Transplantation No drug interventions treatment 2 / 3 unknown_status NCT01603290
Change of Fatigue and Physical Fitness in Hospitalized Hematology Patients No drug interventions Not Available Not Available unknown_status NCT02677064
Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia No drug interventions Not Available Not Available recruiting NCT03469921
Unicentric Retrospective Analysis of a Cohort of 602 Young Adult and Adolescent Patients (AJA), Aged 15 to 30 Years, With Haematological Malignancies, and Managed Between 2000 and 2016 No drug interventions Not Available Not Available completed NCT01728402
Pathogenesis of Hematologic Malignancies No drug interventions Not Available Not Available enrolling_by_invitation NCT06265584
Trial of 2 Step ATG for Prevention of Acute GVHD Post Allogeneic Stem Cell Transplant No drug interventions treatment 2 not_yet_recruiting NCT02752243
CIK-Cells in Relapsing Patients With Acute Leukemia or Myelodysplastic Syndromes After SCT. No drug interventions treatment 1 / 2 unknown_status NCT04195633
Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies treatment 2 recruiting NCT03672851
Study Evaluating Safety and Efficacy of CAR-T Cells Targeting CD123 in Patients With Acute Leukemia No drug interventions treatment 1 terminated NCT03176277
A Study of ONO-7475 in Patients With Acute Leukemias treatment 1 / 2 terminated NCT03735797
Cancer Stem Cells in Acute Leukemia No drug interventions Not Available Not Available active_not_recruiting NCT04331483
A Study to Assess a Physical Activity Program in Children, Adolescents and Young Adults Requiring Hematopoietic Stem Cell Allografts No drug interventions supportive_care Not Available withdrawn NCT01814488
A Phase II Study on Allogeneic Stem Cell Transplantation in Patients With Active Acute Leukemia No drug interventions treatment 2 completed NCT03959007
Impact of Supportive Care on the Experience of Hospitalization of Patients Staying in the Protected Area of the Department of Blood Diseases No drug interventions supportive_care Not Available recruiting NCT03412409
RIC Regimen for Elderly or High Comorbidity Burden Patients Receiving Haplo-HSCT treatment 2 recruiting NCT06315309
Trial of 2 Step ATG for Acute GVHD Prevention Post Myeloablative Allogeneic Stem Cell Transplant treatment 2 not_yet_recruiting NCT00852709
Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias treatment 1 terminated NCT01900509
Bendamustine Hydrochloride, Clofarabine, and Etoposide in Treating Younger Patients With Relapsed or Refractory Hematologic Malignancies treatment 1 completed NCT02930109
A Study of PTX-200 (Triciribine) Plus Cytarabine in Refractory or Relapsed Acute Leukemia treatment 1 / 2 completed NCT03316456
Gut Microbiota in Intestinal Barrier Damage in Acute Leukemia Patients Undergoing Inpatient Induction No drug interventions Not Available Not Available completed NCT05088356
Reduced Intensity Allogeneic HCT in Advanced Hematologic Malignancies w/T-Cell Depleted Graft treatment 1 recruiting NCT03698656
Effect on Patient Quality of Life of Taking Into Account the Spiritual Dimension in Nurse's Care for Haematologic Cancers. No drug interventions Not Available Not Available completed NCT02320656
Predictive Clinical and Biological Parameters in Acute Leukemia, Myelodysplastic Syndromes and Myeloproliferative Disorders-HEMATO-BIO-IPC-2013-015 No drug interventions basic_science Not Available unknown_status NCT05634915
Clinical Study of rATG Individualized Administration in Haploidentical Hematopoietic Stem Cell Transplantation No drug interventions treatment 4 recruiting NCT05035615
Evaluation of the BD OneFlow Acute Leukemia Panel on the BD FACSLyric Flow Cytometer No drug interventions Not Available Not Available completed NCT02823132
Study of the Level of a Protein Which Could Predict the Development of a Fungal Infection in Patients With Acute Leukemia No drug interventions Not Available Not Available completed NCT04767152
Evaluation of Brain Changes in ALL Patients on Therapy No drug interventions diagnostic Not Available recruiting NCT03279900
Hematotoxicity in Acute Lymphoblastic Leukemia Children in Maintenance Phase Therapy No drug interventions Not Available Not Available completed NCT02353559
Emotion And Symptom-focused Engagement (EASE): An Intervention for Individuals With Acute Leukemia No drug interventions treatment Not Available completed NCT02356159
Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation treatment 1 / 2 active_not_recruiting NCT03756675
Haploidentical Peripheral Blood Stem Cell Transplantation for Acute Leukemia No drug interventions Not Available Not Available recruiting NCT05120570
PTCy + Sirolimus/VIC-1911 as GVHD Prophylaxis in Myeloablative PBSC Transplantation No drug interventions supportive_care 1 / 2 recruiting NCT04281199
TBI Using IMRT (VMAT or Tomotherapy) for the Prevention of Pul Toxicities in Patients Undergoing Donor SCT No drug interventions treatment 1 active_not_recruiting NCT02693899
Prospective Study on the Feasibility of Plasma FLT3-Ligand Assay to Achieve a First Estimate of Its Prognostic Value on the Outcome of Patients Treated Intensively for Acute Leukemia No drug interventions Not Available Not Available completed NCT01314599
Clinical Study of PM01183 in Patients With Acute Leukemia or Relapsed/Refractory Myelodysplastic Syndrome Not Available 1 completed NCT02730299
Stem Cell Transplantation With NiCord® (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and MDS treatment 3 active_not_recruiting NCT03016806
Umbilical Cord Blood Transplantation From Unrelated Donors treatment 1 recruiting NCT03493906
Patient Ambassador Support in Newly Diagnosed Patients With Acute Leukemia During Treatment No drug interventions supportive_care Not Available completed NCT03588936
Nivolumab and Tocilizumab for Relapsed Hematological Malignancy Post-allogeneic Transplant treatment 1 terminated NCT00988013
Intensity Modulated Total Marrow Irradiation (IM-TMI) for Advanced Hematologic Malignancies No drug interventions treatment Not Available completed NCT05406817
Study of Radiolabeled Revumenib in Adults With Acute Leukemia treatment 1 recruiting NCT03178617
High-Intensity Parent Intervention Program in Improving Learning and School Functioning in Latino Children With Acute Leukemia or Lymphoblastic Lymphoma No drug interventions supportive_care Not Available active_not_recruiting NCT05902416
Clinical Registration Study of Haplo-HSCT for Elderly Patients With Acute Leukemia/ Myelodysplastic Syndrome No drug interventions Not Available Not Available recruiting NCT01498016
Pharmacokinetic Study of Busulfan in Allogeneic Stem Cell Transplantation in Adult Patients With Acute Leukemia treatment 2 unknown_status NCT00823316
Safety and Efficacy Study of Umbilical Cord Blood-Drived Mesenchymal Stem Cells to Promote Engraftment of Unrelated Hematopoietic Stem Cell Transplantation No drug interventions treatment 1 / 2 completed NCT05589896
A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies No drug interventions treatment 1 / 2 recruiting NCT03970096
Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS) treatment 2 recruiting NCT01709396
ED-TBI Followed By Allogeneic Stem Cell Transplantation For The Treatment Of Refractory AML And Advanced MDS No drug interventions treatment 2 suspended NCT00048958
Cytogenetic Studies in Acute Leukemia and Multiple Myeloma No drug interventions Not Available Not Available active_not_recruiting NCT05328258
Use of GnRHa During Chemotherapy for Fertility Protection treatment 3 recruiting NCT06058858
Incidence and Risks Factors of CMV Reactivation in Patients Receiving of CAR-T Cells for Acute Leukemia and Lymphoma Relapse, a Cohort Study Analysis No drug interventions Not Available Not Available recruiting NCT04202835
ATG Plus PTCy vs ATG for CGVHD Prophylaxis prevention 2 recruiting NCT06026839
Longitudinal Study on the QoL of Pediatric Patients After HSCT and Its Influencing Factors No drug interventions Not Available Not Available not_yet_recruiting NCT01598025
Biparental HLA Haplotype Disparate T-cell Depleted Transplants for Patients Lacking an HLACompatible Donor treatment Not Available terminated NCT03434730
Tocilizumab for the Prevention of Graft Versus Host Disease After Cord Blood Transplantation treatment 2 active_not_recruiting NCT05298930
Feasibility Study to Assess an Adapted Physical Activity Program in Children, Adolescents and Young Adults Requiring Hematopoietic Stem Cell Transplantation No drug interventions supportive_care Not Available completed NCT00520130
Chemotherapy and Unrelated Donor Stem Cell Transplantation for Patients With Cancers of the Blood and Immune System treatment 1 / 2 completed NCT05335226
Combined Haploidentical and Umbilical Cord Blood Allogeneic Stem Cell Transplantation in Patients With Acute Leukemia No drug interventions treatment Not Available unknown_status NCT02344966
Cohort Study of New Prognostic Factors With Peripheral Blood and Bone Marrow Evaluation at the Time of Diagnosis and During Treatment or Thereafter in Acute Leukemia No drug interventions Not Available Not Available unknown_status NCT04767165
Quantitative MRI of Bone Marrow in Patients With Acute Lymphoblastic Leukemia No drug interventions diagnostic Not Available recruiting NCT04224974
Emotion and Symptom-Focused Engagement Trial for Individuals With Acute Leukemia No drug interventions supportive_care Not Available recruiting NCT03314974
Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders No drug interventions treatment 2 recruiting NCT05071482
Flumatinib Versus Imatinib Combined With Chemotherapy for de Novo Ph+ ALL treatment 4 recruiting NCT03969082
Evaluation of Bibliotherapy by Students and Patients With Cancer No drug interventions supportive_care Not Available completed NCT04899882
Physical Fitness Impact of Early Physiotherapy Intervention With a Standardized Exercise Therapy Program in Adult Patients Receiving Intensive Induction Chemotherapy for Treatment of Acute Leukemia During Extended Hospitalization. No drug interventions treatment Not Available recruiting NCT04084327
Immunophenotyping of Acute b Cell Lymphoblstic Leukemia No drug interventions Not Available Not Available unknown_status NCT05428176
A High Intensity Electronic Health Intervention for the Reduction of Learning Disparities in Childhood Cancer Survivors No drug interventions supportive_care Not Available recruiting NCT03042676
Electronic Database for the Follow up of the ATG_FamilyStudy No drug interventions Not Available Not Available completed NCT06279494
Sirolimus+Abatacept+Mycophenolate Mofetil for Prophylaxis of aGVHD in Patients Receiving Haplo-HSCT Who Are Intolerant to Calcineurin Inhibitors prevention 1 / 2 not_yet_recruiting NCT02169791
Nonmyeloablative Haploidentical Transplant Followed by MLN9708 prevention 2 completed NCT02451592
Fungemia in Hematologic Malignancies No drug interventions Not Available Not Available completed NCT00701844
Sharing Our Strength: A Research Study for Bone Marrow/Stem Cell Transplant Survivors No drug interventions treatment Not Available completed NCT05316701
Precision-T: A Randomized Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies No drug interventions treatment 3 active_not_recruiting NCT04339101
Itacitinib, Tacrolimus, and Sirolimus for the Prevention of GVHD in Patients With Acute Leukemia, Myelodysplastic Syndrome, or Myelofibrosis Undergoing Reduced Intensity Conditioning Donor Stem Cell Transplantation treatment 2 active_not_recruiting NCT01502072
Respiratory Syncytial Virus - RSV Protocol treatment 2 completed NCT06058572
Effect of Rifaximin on Gut Bacterial Flora Post Stem Cell Transplant in Patients With Acute Leukemia treatment 2 not_yet_recruiting NCT03669172
Efectiveness of Donor IL-15-stimulated NK Cells Post Transplant Infusion in in Acute Leukemia treatment 1 / 2 completed NCT01321372
An Observational Analysis of Voriconazole Therapeutic Drug Concentration Monitoring, Pharmacogenomics and Clinical Outcome Correlations in High-risk Hematology Patients No drug interventions Not Available Not Available completed NCT02722668
UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep treatment 2 active_not_recruiting NCT00592046
A Phase I Trial of ZIO-101 in Hematologic Cancers treatment 1 completed NCT05974410
Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients Not Available Not Available available NCT03408210
Total Marrow and Lymphoid Irradiation and Chemotherapy for Myelodysplastic Syndrome or Acute Leukemia No drug interventions treatment Not Available unknown_status NCT03138395
iCare3: Monitoring Circulating Cancer DNA After Chemotherapy in MDS and AML No drug interventions Not Available Not Available withdrawn NCT04328714
Interferon γ-Primed Mesenchymal Stromal Cells as Prophylaxis for Acute Graft v Host Disease treatment 1 suspended NCT02345850
Calcineurin Inhibitor-Free Interventions BMT CTN 1301 for Prevention of Graft-versus-Host Disease (BMT CTN 1301) prevention 3 completed NCT05809050
Study of miRNA-155 in Acute Leukemia No drug interventions Not Available Not Available not_yet_recruiting NCT06207123
A Study to Investigate LP-118, Ponatinib, Vincristine and Dexamethasone in Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL) treatment 1 / 2 not_yet_recruiting NCT00899223
Collecting and Storing Blood, Bone Marrow, and Other Samples From Patients With Acute Leukemia, Chronic Leukemia, or Myelodysplastic Syndromes No drug interventions Not Available Not Available active_not_recruiting NCT03408223
Total Marrow and Lymphoid Irradiation and Chemotherapy for High-Risk Acute Leukemia No drug interventions treatment Not Available unknown_status NCT03298321
Action of the Vidaza on the Atrial Fibrillation No drug interventions Not Available Not Available unknown_status NCT04298502
The Molecular Mechanism of CMV-driven NKG2C+NK Cell Expansion in Human No drug interventions Not Available Not Available unknown_status NCT04409379
Association Between Telomere Length and Cardiac Dysfunction No drug interventions Not Available Not Available completed NCT03779854
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant treatment 2 recruiting NCT02344953
Prospective and Retrospective Cohort Study of New Prognostic Factors With Peripheral Blood and Bone Marrow Evaluation at the Time of Diagnosis and During Treatment or Thereafter in Acute Leukemia (Acute Leukemia HSCT Cohort) No drug interventions Not Available Not Available unknown_status NCT01496547
Sequential Intensive Chemotherapy Followed by RIC for Refractory and Relapse AML No drug interventions treatment 2 completed NCT01499147
Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies treatment Not Available completed NCT04674345
Sorafenib Maintenance for Prophylaxis of Leukemia Relapse in Allo-HSCT Recipients With FLT3 Negative Acute Leukemia treatment 2 / 3 unknown_status NCT03278145
Dependence Receptors and Leukemia No drug interventions Not Available Not Available unknown_status NCT01855698
PENELOPE Observational Study: Prophylaxis and Treatment of Arterial and Venous Thromboembolism No drug interventions Not Available Not Available completed NCT04187105
BMT-06: Study of Intensity Modulated Total Marrow Irradiation (IM-TMI) treatment 2 recruiting NCT02038361
Implementation of Innovative Techniques in Routine Diagnosis of Childhood Acute Leukemia: Analysis of Genome and Transcriptome by Micro-array No drug interventions diagnostic Not Available completed NCT05170828
Cryopreserved MMUD BM With PTCy for Hematologic Malignancies treatment 1 withdrawn NCT03297528
Chemotherapy and DLI for Prevention of Second Relapse in Patients With Relapsed Acute Leukemia After Allotransplant No drug interventions prevention 2 unknown_status NCT04904211
Feasiblity and Safety of Home-based Intensive Chemotherapy No drug interventions supportive_care Not Available completed NCT02580071
Chinese Herbal Medicine for Immune Reconstitution Following HSCT in Acute Leukemia Patients No drug interventions supportive_care Not Available completed NCT02440178
Micafungin Prophylaxis During 1st Induction Chemotherapy for De Novo Acute Leukemia prevention 2 completed NCT02445378
Aromatherapy and Essential Oils in Improving Insomnia and Other Symptoms in Patients With Newly Diagnosed Acute Leukemia Undergoing Chemotherapy No drug interventions supportive_care Not Available completed NCT05587088
Evaluation of the Safety and Efficacy of Esperanza Extract (PA001) No drug interventions treatment 1 / 2 not_yet_recruiting NCT04904588
HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide treatment 2 recruiting NCT06001788
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia treatment 1 recruiting NCT01660607
Phase 1-2 MAHCT w/ TCell Depleted Graft w/ Simultaneous Infusion Conventional and Regulatory T Cell No drug interventions treatment 1 / 2 completed NCT02246907
Exercise and Quality of Life in Leukemia Patients No drug interventions supportive_care Not Available completed NCT01036009
A Study of Withdrawal of Immunosuppression and Donor Lymphocyte Infusions Following Allogeneic Transplant for Pediatric Hematologic Malignancies No drug interventions treatment 2 completed NCT05320809
Study of 3D189 in Patients With Hematologic Malignancies treatment 1 active_not_recruiting NCT03743909
Expression of Aberrant CD Markers in Acute Leukemia:Retrospective Study in South Egypt Cancer Institute No drug interventions Not Available Not Available unknown_status NCT03792256
Palbociclib in Combination With Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LL) treatment 1 active_not_recruiting NCT01362985
Analysis of Data Collected in the European Group for Blood and Marrow Transplantation (EBMT) Registry for Off-Label Transplant Use of Plerixafor No drug interventions Not Available Not Available completed NCT01239485
Study of IRNEA (Irinotecan, Etoposide, Cytarabine) for Refractory or Relapsed Acute Leukemia in Children and Adolescents treatment 1 unknown_status NCT04013685
Precision-T: A Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies No drug interventions treatment 1 active_not_recruiting NCT03267485
Expression of TET1 Gene in Acute Leukaemia No drug interventions Not Available Not Available unknown_status NCT06001385
HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis treatment 2 recruiting NCT02208037
Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203) prevention 2 completed NCT05053100
Understanding the Risk of Blood Clots and Bleeding in Patients With Hematological Malignancies, HAT Study No drug interventions Not Available Not Available recruiting NCT04451200
Sequential and Personalized PK-guided Busulfan Administration in the Frame of the Conditiong Regimen for Allo-HSCT in Patients With Malignant Hemopathies Ineligible for the Standard Myeloablative Conditioning treatment 2 not_yet_recruiting NCT03595800
Extension of a Study of Allogeneic Hematopoietic Stem Cell Transplantation From One Haplotype Mismatch Related Donor or From an Unrelated Donor to Younger Patients Eligible for Reduced-intensity Conditioning Regimen No drug interventions treatment 3 unknown_status NCT01509300
HLA-haploidentical Hematopoietic Stem Cell Transplantation for Children and Adolescents With Acute Leukemia, Myelodysplastic Syndrome and Solid Tumors treatment 1 / 2 unknown_status NCT03128359
High Dose Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil in Preventing Graft Versus Host Disease in Patients With Hematological Malignancies Undergoing Myeloablative or Reduced Intensity Donor Stem Cell Transplant supportive_care 2 completed NCT01020175
Peripheral Blood (PB) Versus Bone Marrow (BM) in Allogeneic Stem Cell Transplantation No drug interventions treatment 3 completed NCT01615042
Phase I Study of Lenalidomide in Patients With Acute Leukemia treatment 1 terminated NCT03739606
Flotetuzumab in Treating Patients With Recurrent or Refractory CD123 Positive Blood Cancer No drug interventions treatment 2 withdrawn NCT04151706
CD34 Selected Allogeneic HCT w/ Myeloablative Conditioning Plus CD8+ Memory TCell Infusion in MDS, AL and CML treatment 2 completed NCT00273936
Trial of AVN-944 in Patients With Advanced Hematologic Malignancies Not Available 1 completed NCT01661413
Nausea and Vomiting in Children Receiving Chemotherapeautic Monotherapy No drug interventions Not Available Not Available completed NCT03232619
CD19-CART Treatment for ALL No drug interventions treatment 1 / 2 completed NCT03959241
TAC/MTX vs. TAC/MMF/PTCY for Prevention of Graft-versus-Host Disease and Microbiome and Immune Reconstitution Study (BMT CTN 1703/1801) prevention 3 completed NCT05735717
MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies treatment 2 recruiting NCT06575296
Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant treatment 1 not_yet_recruiting NCT03810196
CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT No drug interventions treatment Not Available recruiting NCT01350258
Bone Marrow Transplant Using a Reduced Intensity Regimen That is Given in Two Steps treatment 1 / 2 terminated NCT04551235
Establishing Automatic Method of Counting and Classify Bone Marrow and Peripheral Blood Cells No drug interventions Not Available Not Available unknown_status NCT01557686
Health Counseling and Exercise in Patients With Acute Leukemia - Pilot Study No drug interventions supportive_care 0 completed NCT04597086
Bright White Light Therapy for the Improvement of Sleep, Fatigue, Distress, Depression, and Anxiety in Hospitalized Leukemia Patients No drug interventions supportive_care Not Available completed NCT06356922
Study Assessing RLT Using [177Lu]Lu-PentixaTher for Relapsed/Refractory CXCR4+ Acute Leukemia. treatment 1 / 2 not_yet_recruiting NCT05739630
M-PTCy vs BuCy in Haploidentical HSCT for Acute Leukemia treatment 2 / 3 recruiting NCT01956630
Clinical Study of DC Plus CIK for Patients With Relapse Acute Leukemia After Allo-HSCT No drug interventions treatment 1 / 2 unknown_status NCT03364257
iDTECT Blood Performance for the Identification of Viral or Bacterial Pathogens in Febrile Neutropenic Patients No drug interventions Not Available Not Available unknown_status NCT02822326
Phase I Study of CD19-CAR-T2 Cells for Patients With Chemotherapy Resistant or Refractory CD19+ Acute Leukemia No drug interventions treatment 1 unknown_status NCT06076226
A Retrospective Study on the Relationship Between Donor Leukocyte Telomere Length and Prognosis of Acute Leukemia Patients Treated With Allogeneic Hematopoietic Stem Cell Transplantation No drug interventions Not Available Not Available recruiting NCT04099966
AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion treatment 2 recruiting NCT05654766
Assesment of the Functional Activity of Platelets for the Differential Diagnosis of Thrombocytopathies No drug interventions Not Available Not Available not_yet_recruiting NCT06211166
Assessment of Measurable Residual Disease in Allo-HSCT Using Digital Polymerase Chain Reaction No drug interventions Not Available Not Available recruiting NCT04182074
Monitoring the Diagnosis and Management of Acute Leukaemia In Pregnancy Study. No drug interventions Not Available Not Available completed NCT01404520
Patient Activation, Counseling and Exercise - Acute Leukemia (PACE-AL) No drug interventions supportive_care Not Available completed NCT03096782
Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or Lymphoma treatment 2 completed NCT02877082
Tacrolimus, Bortezomib, & Thymoglobulin in Preventing Low Toxicity GVHD in Donor Blood Stem Cell Transplant Patients prevention 2 terminated NCT01385891
Clove In The Treatment Of Relapsed Or Resistant Acute Leukemia In Children treatment 2 / 3 completed NCT01624701
Clinical Ex Vivo Expansion of Human Umbilical Cord Blood Stem and Progenitor Cells No drug interventions treatment 1 / 2 terminated NCT04969601
Anti-Covid-19 Vaccine in Children With Acute Leukemia and Their Siblings prevention 1 / 2 completed NCT05521204
Olverembatinib for FGFR1-rearranged Neoplasms treatment 2 recruiting NCT03050268
Familial Investigations of Childhood Cancer Predisposition No drug interventions Not Available Not Available recruiting NCT04157569
CtDNA After Chemotherapy in Elderly Patients With Acute Leukemia No drug interventions Not Available Not Available recruiting NCT02487069
Allo-HSCT With Alternative Donor in Treatment of Hematologic Malignancy No drug interventions treatment Not Available completed NCT01695512
Diagnostic Study of Combined Biomnarker Testing in Bronchoalveolar Lavage Samples of Immunocompromised Patients No drug interventions Not Available Not Available unknown_status NCT01336712
Total Body Irradiation/Fludarabine Based Ablative Haploidentical Transplant for Hematologic Diseases No drug interventions treatment 2 completed NCT04552912
Physical Activity to Improve Patient Reported Outcomes for Adults With Acute Leukemia No drug interventions supportive_care Not Available completed NCT05601895
The Gut Microbiome in FLT3- AL Undergoing Allo-HSCT With Or Without Sorafenib Maintenance No drug interventions Not Available Not Available recruiting NCT01472055
Pharmacokinetic Study of Fludarabine in Pediatric Hematopoietic Stem Cell Transplantation No drug interventions treatment 2 unknown_status NCT01214655
A Study for Patients With Acute Leukemia No drug interventions treatment 1 terminated NCT06421155
Brain MRF in Children, Adolescents and Young Adults With Acute Leukemia No drug interventions diagnostic Not Available not_yet_recruiting NCT05068401
Cryopreserved MMUD BM With PTCy for Hematologic Malignancies treatment 1 not_yet_recruiting NCT00914628
Efficacy Study on the Strategy of HSV-Tk Engineering Donor Lymphocytes to Treat Patients With High Risk Acute Leukemia No drug interventions treatment 3 terminated NCT02990104
First Report, Five Years Experience of the Acute Leukemia Work Group No drug interventions Not Available Not Available unknown_status